Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
USP7 antisense RNA 1 (USP7-AS1) is an antisense long non-coding RNA (lncRNA) transcribed from the strand opposite the USP7 (ubiquitin specific peptidase 7) gene. Antisense RNAs like USP7-AS1 generally play roles in the regulation of gene expression at various stages, including transcriptional and post-transcriptional levels. They function by interacting with their sense (protein-coding) counterparts, modulating gene activity either in cis (locally) or trans (distal effects), often via influences on chromatin structure, RNA stability, or transcriptional machinery. While the biological function of USP7-AS1 specifically has not been described in detail in current curated literature, the molecular class of antisense lncRNAs is increasingly recognized for its regulatory capacity, particularly in gene silencing, epigenetic modulation, and transcriptional interference[2]. Evidence for a direct disease association or therapeutic targeting of USP7-AS1 is presently lacking in the search results provided. Notes: - USP7-AS1 should not be confused with USP7, which is a ubiquitin-specific protease and recognized therapeutic target in cancer and other disease contexts[1][3][5]. - There is no evidence or report in search results that USP7-AS1 serves as a therapeutic target, marker, or is functionally druggable at present. - If more precise or disease-specific associations for USP7-AS1 emerge, structured annotations can be updated. - No errors, misspellings, or issues are detected with the current target name based on the search results.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on USP7 antisense RNA 1 (USP7-AS1).